A Clinical Trial to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects
This study will adopt a Single-center, Single-arm, Open, Fixed Sequence design to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects.
Locally Advanced or Metastatic Solid Tumor
DRUG: VC004 and Itraconazole|DRUG: VC004 and rifampicin
Maximum Observed Plasma Concentration (Cmax), Maximum Observed Plasma Concentration (Cmax), Day1-Day16|Area Under the Curve From Time Zero to Last Quantifiable Concentration(AUCï¼‰, Day1-Day16
This study will adopt a Single-center, Single-arm, Open, Fixed Sequence design to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects.